Serena Williams Weight Loss: Zepbound, Diet, Exercise (2025)

When one of the greatest athletes in history shares her weight loss journey, people pay attention. Serena Williams didn’t just drop pounds—she sparked a global conversation about GLP-1 drugs, elite fitness, and what “healthy” really means. In August 2025, she announced she had lost 31 pounds using Zepbound (tirzepatide), a dual GLP-1/GIP agonist, and said she experienced no side effects. This article breaks down exactly how she did it, what Zepbound is, and what her experience reveals about weight management for athletes and everyday people alike.

Weight lost: 31–34 pounds (as of Aug 2025 – Jan 2026) ·
Medication used: Zepbound (tirzepatide), a GLP-1/GIP agonist ·
Timeframe: Approximately one year (starting late 2024) ·
Side effects reported: None ·
Public announcement: Women’s Health magazine, August 2025 ·
Partner brand: Ro (telehealth platform)

The snapshot facts table compiles the key verified numbers from Williams’s public disclosures.

How Did Serena Williams Lose So Much Weight?

Her GLP-1 Medication: Zepbound

• Williams began taking Zepbound (tirzepatide) in late 2024, according to Healthline.
• She lost 31–34 pounds over approximately one year (Healthline).
• The drug is a dual GLP-1/GIP receptor agonist approved for weight management (Jeremy Korman MD).

Combination with Diet and Exercise

Williams emphasized that Zepbound was an enhancer, not a replacement. She told Women’s Health that the drug “helped me enhance everything that I was already doing — eating well, working out, taking care of my body” (cited by Healthline). She maintained her regular training routine and balanced nutrition throughout the process.

Timeline of Her Weight Loss

• Summer 2024: Williams first tried a GLP-1 medication, then stopped (Healthline).
• Late 2024: She began Zepbound through Ro (Healthline).
• August 25, 2025: Announced 31‑lb weight loss in Women’s Health (Healthline).
• January 30, 2026: Says she lost 34 pounds and is “the healthiest I have ever been” (NBC News).

Did Serena Williams Use Ozempic?

Ozempic vs. Zepbound: What’s the Difference?

• Ozempic contains semaglutide, a GLP-1 agonist alone; Zepbound contains tirzepatide, a dual GLP-1/GIP agonist (Jeremy Korman MD).
• Zepbound is specifically approved for weight management; Ozempic is primarily for type 2 diabetes (though often used off‑label for weight) (Jeremy Korman MD).

Why People Mistake GLP-1 Drugs

Many online headlines blur the line between Ozempic, Wegovy, and Zepbound. A YouTube video titled “Serena Williams Ozempic Transformation” actually shows Zepbound content. The confusion stems from Ozempic becoming a household name for weight loss through social media.

Williams’s Explicit Statement on Her Medication

Williams made it clear: she used Zepbound, not Ozempic. She partnered with Ro to obtain the medication. Her husband, Alexis Ohanian, is an investor in and board member of Ro (per Healthline).

Why Did Serena Williams Lose So Much Weight?

Health Goals Over Aesthetics

Williams stated that her goal was overall wellness, not just a number on the scale. She told Women’s Health that she wanted to feel healthier and have more energy (cited by Healthline).

Medical and Athletic Benefits

For elite athletes, carrying extra weight can strain joints and reduce performance. Williams, who retired from tennis in 2022, focused on midlife health. A 2026 update she shared with NBC News emphasized she is “the healthiest I have ever been.”

Public Reaction and Privacy

The announcement generated both praise and criticism. Some questioned why a fit athlete needed weight‑loss medication. Williams maintained that her choice was personal and informed by medical advice. The University of California, Irvine framed her case as a midlife‑health discussion rather than celebrity gossip.

What Is Zepbound and How Does It Work?

Tirzepatide Mechanism

• Zepbound’s active ingredient, tirzepatide, activates both GLP-1 and GIP receptors (dual agonist) (Jeremy Korman MD).
• This dual action increases insulin secretion, slows gastric emptying, and reduces appetite (Healthline).

Comparison to Other GLP-1 Drugs

A New England Journal of Medicine study found tirzepatide superior to Wegovy for obesity management after 72 weeks. Zepbound is approved for people with a BMI ≥30 (obesity) or ≥27 with a weight‑related condition (Jeremy Korman MD).

Common Side Effects and Risks

• Nausea, vomiting, diarrhea, and constipation are common, especially during dose escalation (Healthline).
• Williams reported experiencing none of these (Healthline).
• Long‑term effects for non‑diabetic users remain under study; the drug carries a boxed warning for thyroid C‑cell tumors.

Six core specifications of Zepbound, one pattern: it combines two hormonal pathways for greater efficacy than single‑agonist drugs.

Serena Williams Weight Loss Before and After

Physical Transformation

Williams shared before‑and‑after photos with Women’s Health in August 2025. The images showed a visibly slimmer frame, though she did not disclose specific starting or ending weights. The loss of 31–34 pounds represented a notable change for her athletic build.

Changes in Training Regimen

She maintained her normal workout schedule, which includes tennis drills, strength training, and cardio. The medication helped her “enhance everything” she was already doing (per Healthline).

Media and Fan Reactions

Reddit threads and social media buzzed with support and skepticism. Some fans praised her honesty; others questioned the necessity for a professional athlete. The UCI‑hosted summary noted that her story reframes GLP‑1 use as a midlife health tool rather than a vanity project.

Steps to a Safe GLP‑1 Weight Loss Journey

1. Consult a healthcare provider to assess whether your BMI or health conditions qualify (per FDA guidelines).
2. Choose an appropriate medication – Zepbound (tirzepatide) or semaglutide (Wegovy/Ozempic) based on your profile.
3. Combine with diet and exercise – as an endocrinologist told Healthline, these drugs work best when paired with lifestyle changes.
4. Monitor side effects – nausea and GI issues are common. Williams had none, but many do.
5. Work with a telehealth partner like Ro (Williams’s choice) for ongoing support and dosing adjustments.
6. Set realistic expectations – typical weight loss is 5–15% of body weight over 6–12 months.

Timeline of Serena Williams’s Weight Loss Journey

• Summer 2024: Williams first tries a GLP‑1 medication, then stops (Healthline).
• Late 2024: Begins Zepbound through Ro (Healthline).
• August 25, 2025: Announces 31‑lb loss in Women’s Health (Healthline).
• August 2025: BBC, Healthline, and NBC News cover the announcement.
• January 30, 2026: Says she lost 34 pounds and is “the healthiest I have ever been” (NBC News).
• Ongoing: Williams continues Ro partnership; public discussion on athlete GLP‑1 use continues.

Quotes from Williams and Experts

“GLP-1 helped me enhance everything that I was already doing — eating well, working out, taking care of my body.”

– Serena Williams, Women’s Health (via Healthline)

“I am the healthiest I have ever been and have lost 34 pounds.”

– Serena Williams, NBC News (January 30, 2026)

“Tirzepatide works best when combined with regular exercise and a balanced, low-calorie diet.”

– Endocrinologist, as quoted by Healthline

For athletes and everyday people alike, the key takeaway is that GLP‑1 drugs can be powerful aids, but they work best as complements to lifestyle habits. Serena Williams’s case also raises practical questions: What does this mean for you if you’re considering similar treatment? The choice is personal, but the data is clear—these drugs require medical supervision, realistic expectations, and a commitment to long‑term health, not quick fixes. For the elite performer or the midlife patient, the implication is the same: use the tool, but don’t let the tool define the journey.

Frequently asked questions

Related reading: Best Group Exercises at Home · Quick Workouts at Home